In the BioHarmony Drug Report Database

"Preview" Icon

Pentazocine

Talwin (pentazocine) is a small molecule pharmaceutical. Pentazocine was first approved as Talwin on 1982-01-01. It is used to treat pain in the USA. The pharmaceutical is active against sigma non-opioid intracellular receptor 1. In addition, it is known to target delta-type opioid receptor, mu-type opioid receptor, and kappa-type opioid receptor.

 

Trade Name

 

Talwin
 

Common Name

 

pentazocine
 

ChEMBL ID

 

CHEMBL100116
 

Indication

 

pain
 

Drug Class

 

Narcotic antagonists/agonists (6,7-benzomorphan derivatives)

Image (chem structure or protein)

Pentazocine structure rendering